Preview Mode Links will not work in preview mode

Oct 24, 2024

Featuring perspectives from Dr Bhavana (Tina) Bhatnagar, Dr Amanda Blackmon, Dr Jorge Cortes, Dr Michael J Mauro and Dr Neil P Shah, including the following topics:

  • Recently presented data affecting the treatment of newly diagnosed chronic myeloid leukemia (CML) (0:00)
  • Case: A man in his mid 40s with newly diagnosed CML with tyrosine kinase inhibitor (TKI) tolerability issues but a good response (24:51)
  • Case: A woman in her mid 80s with chronic-phase CML (CP-CML) with translocation (9;22) (40:26)
  • Case: A woman in her mid 80s with CP-CML and notable comorbidities (43:12)
  • Case: A woman in her early 50s with CP-CML intolerant to dasatinib (51:22)
  • Case: A woman in her late 50s with CP-CML and TKI withdrawal syndrome (1:01:22)
  • Case: A woman in her mid 50s with accelerated-phase CML (1:08:22)
  • Case: A woman in her early 70s with CP-CML and a suboptimal response to second-line TKI (1:17:00)
  • Case: A man in his mid 30s with CP-CML and a complex variant Ph-positive translocation (1:23:24)
  • Case: A man in his mid 30s with CP-CML and a T315I mutation (1:28:55)

CME information and select publications